Literature DB >> 11279795

Numerical selection of optimal tumor imaging agents with application to engineered antibodies.

L E Williams1, A M Wu, P J Yazaki, A Liu, A A Raubitschek, J E Shively, J Y Wong.   

Abstract

Three analytic indicators were used to compare five members of a monoclonal antibody (Mab) family. The cognates consisted of the genetically engineered intact chimeric IgGI (cT84.66) and related engineered fragments [scFv, diabody, minibody, F(ab')2] reactive against the same epitope of carcinoembryonic antigen (CEA). All analyses were based on radioiodinated Mabs targeting to colorectal xenografts of LS174T tumors in nude mice. Affinity constants were evaluated initially. A second indicator was the imaging figure of merit (IFOM) which determines how rapidly a statistically significant tumor image can be acquired. Finally, deconvolution was used to determine tumor temporal response to an arterial bolus. This last analysis gave the possible tumor accumulation in the absence of normal tissue sequestration. Affinities were all in excess of 10(8) M-1 and were highest for the divalent Mabs. Using the IFOM criterion, an 131I label was best suited as a radiolabel for the intact (IgG) T84.66, while an 123I label indicated optimal imaging with either minibody or F(ab')2. Deconvolution analyses showed that divalent members behaved similarly while the univalent member (scFv) had a tumor residence time smaller by an order of magnitude. The diabody had the largest impulse response function, but renal uptake may limit its present usefulness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279795     DOI: 10.1089/108497801750095989

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  24 in total

1.  Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.

Authors:  Dhaval K Shah; Alison M Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-06       Impact factor: 2.745

2.  Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

Authors:  Vania Kenanova; Tove Olafsen; Desiree M Crow; Gobalakrishnan Sundaresan; Murugesan Subbarayan; Nora H Carter; David N Ikle; Paul J Yazaki; Arion F Chatziioannou; Sanjiv S Gambhir; Lawrence E Williams; John E Shively; David Colcher; Andrew A Raubitschek; Anna M Wu
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

Review 3.  Immuno-positron emission tomography in cancer models.

Authors:  Smitha Reddy; Matthew K Robinson
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

4.  Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging.

Authors:  Kelly D Orcutt; Gregory P Adams; Anna M Wu; Matthew D Silva; Catey Harwell; Jack Hoppin; Manabu Matsumura; Masakatsu Kotsuma; Jonathan Greenberg; Andrew M Scott; Robert A Beckman
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

5.  Using a single parameter to describe time-activity curves.

Authors:  Cheuk S Kwok; Paul H Frankel; George Lopatin; Lawrence E Williams
Journal:  Cancer Biother Radiopharm       Date:  2014-01-02       Impact factor: 3.099

6.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

7.  A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.

Authors:  Lin Li; James Bading; Paul J Yazaki; Amitkumar H Ahuja; Desiree Crow; David Colcher; Lawrence E Williams; Jeffrey Y C Wong; Andrew Raubitschek; John E Shively
Journal:  Bioconjug Chem       Date:  2007-11-08       Impact factor: 4.774

8.  18F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice.

Authors:  Kirstin A Zettlitz; Richard Tavaré; Wen-Ting K Tsai; Reiko E Yamada; Noel S Ha; Jeffrey Collins; R Michael van Dam; John M Timmerman; Anna M Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-11-19       Impact factor: 9.236

9.  Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer.

Authors:  Sai Kiran Sharma; Melinda Wuest; Jenilee D Way; Vincent R Bouvet; Monica Wang; Frank R Wuest
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-07-06

10.  Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Biomark Insights       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.